Tolvaptan HCl Tablets
Product Description
Jiangsu Hengrui Medicine Co., Ltd.
-
CN
-
2015On CPHI since
-
2Certificates
-
5000+Employees
Company types
Categories
Jiangsu Hengrui Medicine Co., Ltd.
-
CN
-
2015On CPHI since
-
2Certificates
-
5000+Employees
Company types
More Products from Jiangsu Hengrui Medicine Co., Ltd. (99)
-
Product Irinotecan HCl Injection
The main use of this product is in colon cancer, in particular, in combination with other chemotherapy agents.
Strength: 40mg/2ml; 100mg/5ml.
NMPA approved.
MA issued from US-FDA, Japanese PMDA.
-
Product Letrozole Tablets
Letrozole is an oral non-steroidal aromatase inhibitor for the treatment of hormonally-responsive breast cancer after surgery.
Strength: 2.5mg.
Letrozole Tablets is approved by NMPA and EU GMP (Spain and Netherlands), and have MA issued from US-F... -
Product Oxaliplatin for Injection
Oxaliplatin is a platinum-based antineoplastic agent used in cancerchemotherapy.
Strength: 50mg/vial.
It is the first injection product of domestic pharmaceutical enterprises approved to get launched in the European market.
MA issued from Spain, Netherlands CBG and UK MH... -
Product Fondaparinux Injection
Fondaparinux is an anticoagulant medication chemically related to low molecular weight heparins.
Strength: 0.5ml:2.5mg; 0.4ml:0.5mg; 0.6ml:7.5mg; 0.8ml:10mg.
It is approved by US-FDA. -
Product Thiotepa for Injection
Thiotepa for Injection USP is an alkylating agentused to treat cancer.
Strength: 15mg/vial
Approved by US-FDA.
Dossiers for EU market have been filed.
-
Product Lopamidol Injection
It is a kind of contrast agent.
Strength:
(300mg iodine/ml) 61% *50ml *100ml
(370mg iodine/ml) 76% *50ml *100ml *150ml *200ml
It is in R&D stage. -
Product Oxaliplatin Injection
Oxaliplatin is a platinum-based antineoplastic agent used in cancerchemotherapy.
Strength: 50mg/10ml; 100mg/20ml.
NMPA approved; MA issued from US-FDA.
-
Product Capecitabine Tablets
It is an orally-administered chemotherapeutic agent used in the treatment of numerous cancers. It is a prodrug that is enzymatically converted to 5-fluorouracil (5-FU) in the body.
Strength: 150mg; 500mg
CFDA approved.
US-AN... -
Product Carmustine for Injection (with diluent)
It is a medication used mainly for chemotherapy and sometimes for immunosuppression before organ transplantation. It is used in the treatment of several types of brain cancer (including glioma, glioblastoma multif... -
Product Daptomycin for Injection
Daptomycin is a lipopeptide antibiotic used in the treatment of systemic and life-threatening infections caused by Gram-positive organisms.
Strength: 500mg/vial.
This product has been approved by NMPA in 2016.
It is approved by US-FDA. -
Product Ethiodized Oil Injection
It is used to outline structures in radiological investigations. It is used in chemoembolization applications as a contrast agent in follow-up imaging. It is also used in lymphangiography, the imaging of the lymphatic system. It has an additional use in gastric variceal obl... -
Product Iodixanol Injection
Iodixanol is a contrast agent commonly used duringcoronary angiography.
This product has been approved by NMPA.
Strength: 320mgI/ml (100ml)
Iodixanol Injection USP (Packaged in PP bottles)---Strength: 320mgI/ml (50ml; 100ml; 150ml; 200ml)
Approve...
Jiangsu Hengrui Medicine Co., Ltd. resources (1)
-
Brochure Hengrui Medicine - Company Details
Hengrui Medicine is dedicated to research, developing, and promoting innovative medicine with high quality.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance